H2 Blocker

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
257	肝型糖原病	1

257. 肝型糖原病

臨床試験数 : 14 / 薬物数 : 27 - (DrugBank : 7) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 8

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04990388 (ClinicalTrials.gov)	October 18, 2021	26/7/2021	Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type I ...	A Phase 1/2 First-in-human, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sing ...	Glycogen Storage Disease Type III	Biological: UX053;Other: Placebo;Drug: Antipyretic;Drug: H2 Blocker;Drug: H1 Blocker	Ultragenyx Pharmaceutical Inc	NULL	Active, not recruiting	18 Years	N/A	All	8	Phase 1/Phase 2	United States;Canada;France;Italy;Spain;United Kingdom

First Previous1Next Last